Biotech Values

[tinkershaw]

By “horse needle,” I mean a product/needle combination that causes injection pain.

That definition of "horse needle" does accurately describe the present state of bydureon, although the term itself IMO is unduly inflammatory, but you probably have a history of its use that I'm not aware of which would make it appropriate for those who understand the history. I know I use terms like that as well that I have developed a historical basis for, that may sound inflammatory, but are just my particular label for an event. The once weekly bydureon injection does have some injection pain unlike what most diabetics are use to these days.

Despite this injection pain (which I think is overstated by some) patient compliance and continuance in trials has been rather good, in fact better than with byetta, and I would presume better than victoza as well looking at the adverse events. Which puts the pain aspect into context. This clincal trial seems to be just another gremlin in the bydureon/byetta franchise. Never living up to its potential.

Tinker.